EN DE
STOCK COMPARISON

Bayer Cropscience vs Corteva: Fair Value & Quality

Both stocks run through our valuation models. Here is how Bayer Cropscience (BAYERCROP) and Corteva (CTVA) compare, as of Aug 13, 2026.

As of Aug 13, 2026, Fair Value Calculator sees Bayer Cropscience as the less overvalued of the two: Bayer Cropscience trades at ₹4,115 versus a fair value of ₹2,242 (-46%), while Corteva trades at $76.22 versus $27.81 (-64%).
Bayer Cropscience
BAYERCROP.NSE · INR · Materials
-46%
upside to fair value
overvalued
Price₹4,115
Fair Value₹2,242
Quality77/100
Corteva
CTVA · USD · Materials
-64%
upside to fair value
overvalued
Price$76.22
Fair Value$27.81
Quality71/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Bayer CropscienceCorteva
Valuation
27.3×P/E (TTM)46.3×
3.32×P/S (TTM)3.20×
6.35×P/B2.37×
19.9×EV/EBITDA13.2×
PEG1.44×
3.6%Dividend yield0.9%
₹150Dividend per share$0.72
Profitability
12%Net margin7%
15%Operating margin24%
24%Return on equity5%
9%Return on assets4%
Growth
5%Revenue growth (YoY)11%
3.4%Avg. growth/yr (3Y)-0.1%
5.9%Avg. growth/yr (5Y)4.1%
Balance & size
Debt / equity0.07×
$2BMarket cap$57B
healthyGrowth qualityhealthy

Bayer Cropscience leads: 7 to 5 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Bayer Cropscienceof which business quality 76 · market factors 37 Cortevaof which business quality 69 · market factors 59
ProfitabilityMargins and returns on capital today
68
30
Quality GrowthAre margins and returns improving?
44
48
CashflowEarnings quality: real cash, not paper profit
80
80
Fin. StrengthBalance sheet, leverage, solvency risk
92
74
InvestmentDisciplined investing over empire-building
84
97
Low VolatilityCalm price path (market factor)
92
84
MomentumPrice trend over the last 3–12 months (market factor)
22
48
52W MomentumDistance to the 52-week high (market factor)
0
50
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Bayer Cropscience

DCF Models₹3,456
Earnings-Based₹1,562
Dividend Discount₹2,203
Multiples₹2,235
Asset-Based₹442
Growth DCF₹3,965
Economic Profit₹1,595
Growth Earnings₹2,147

24 of 26 models see the stock below the current price.

Corteva

DCF Models$50.58
Earnings-Based$30.99
Dividend Discount$9.27
Multiples$35.54
Asset-Based$24.19
Growth DCF$57.96
Economic Profit$34.06
Growth Earnings$21.85

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Bayer Cropscience
Bear ₹1,756Fair Value ₹2,242Bull ₹2,728
₹4,115 = current price (white tick)
Corteva
Bear $20.86Fair Value $27.81Bull $34.76
$76.22 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Bayer Cropscience · Materials

Quality score77 · Top 25%
Fair value upside-46% · below median

Corteva · Materials

Quality score71 · Top 25%
Fair value upside-64% · bottom 25%

Bottom line

As of Aug 13, 2026, Fair Value Calculator sees Bayer Cropscience as the less overvalued of the two: Bayer Cropscience trades at ₹4,115 versus a fair value of ₹2,242 (-46%), while Corteva trades at $76.22 versus $27.81 (-64%).

Bayer Cropscience has the higher quality score (77/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.